Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ONO-2952

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
In preclinical models, it has been reported that social defeat stress activates microglial cells in the CNS. Translocator protein… Expand
Is this relevant?
2017
2017
Summary Background ONO‐2952 is a novel and selective inhibitor of translocator protein 18 kDa that reduces stress‐induced… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2017
2017
ONO-2952, a novel antagonist of translocator protein 18 kDa (TSPO), binds with high affinity to TSPO in rat brain and human tumor… Expand
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2017
2017
We have previously shown that ONO-2952, a novel 18-kDa translocator protein (TSPO) antagonist, inhibits stress-induced… Expand
  • table 1
  • table 4
  • table 5
Is this relevant?
2017
2017
 
Is this relevant?
2016
2016
Abbreviations This article has not been copyedited and formatted. The final version may differ from this version. Abstract We… Expand
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
Accumulating evidence has shown the pathophysiological significance of the translocator protein 18 kDa (TSPO) in the central… Expand
Is this relevant?
2015
2015
PURPOSE To investigate safety, tolerability, and pharmacokinetic properties of single and multiple doses of novel translocator… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
Is this relevant?
2015
2015
Background / Aims: Sleep disorders are often associated to functional gastro-intestinal disorders (FGIDs). The aim of this study… Expand
Is this relevant?